| NCT06107803 | A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in Adult Subjects With Moderate to Severe Negative Symptoms of Schizophrenia | COMPLETED | PHASE1 | 2023-10-13 | 2024-01-12 | 2024-01-12 |
| NCT03446846 | A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder | COMPLETED | PHASE2 | 2018-03-30 | 2019-12-13 | 2019-11-21 |
| NCT03397134 | Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of Schizophrenia | COMPLETED | PHASE3 | 2017-12-15 | 2021-02-15 | 2020-05-26 |
| NCT03072056 | A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers | COMPLETED | PHASE1 | 2017-01-09 | 2017-07-07 | 2017-07-07 |
| NCT03038646 | A Pharmacokinetic Study of Modified Release (MR) Formulations of MIN-101 in Healthy Subjects | COMPLETED | PHASE1 | 2016-11-30 | 2017-04-20 | 2017-04-20 |
| NCT02232529 | Pharmacokinetic Study of MIN-101 in Healthy Subjects | COMPLETED | PHASE1 | 2014-09 | 2015-02 | 2015-02 |